View abstract

Cet abstract a été assigné à sessions

Type de présentation	Oral presentation
Titre	Driving Forces and Perceived Barriers for the Adoption of Novel Endothelial Cell Therapies: An International Survey of Corneal Surgeons

But	To evaluate corneal transplant surgeons’ current practice pattern and their interest and adoption attitudes toward novel endothelial cell replacement via an online survey.
Méthodes	The online survey contained 25 questions (13 single-choice, 12 multi-choice) separated in the 4 sections “General Demographics and Practice Patterns,” “New Corneal Endothelial Cell Replacement Therapies,” “Perceived Barriers,” and “Surgeon Perspectives on Graft Design for Tissue-Engineered Endothelial Grafts.” A total of 116 responses were evaluated.
Résultats	Most respondents (97.4%, n = 113) would consider the adoption of novel, commercially available cell replacement therapies in the future. Ease of surgical handling, better clinical outcomes, and donor tissue shortages were seen as the main driving forces for adoption. Although being acknowledged as an easier procedure, most respondents expressed that cell injection should be restricted to corneal specialists and not be performed by comprehensive ophthalmologists.
Conclusion	The survey shows a positive attitude for adopting new endothelial cell replacement therapies among corneal surgeons. Perceived barriers and expected training requirements for the clinical adoption of the new therapies were identified and should be addressed to ensure a successful clinical translation.
Conflit d'intérêt	Non

Auteurs 1

Nom	LUAN
Initiales	Y
Institut	Vrije Universiteit Brussel (VUB),Universitair Ziekenhuis Brussel (UZB)
Ville	Brussels

Auteurs 2

Nom	Ní Dhubhghaill
Initiales	S
Institut	Department of Ophthalmology, UZ Brussel / Vrije Universiteit Brussel (VUB)
Ville	Brussels

Auteurs 3

Nom	Rose-Nussbaumer
Initiales	J
Institut	Byers Eye Institute, Department of Ophthalmology, Stanford University
Ville	Palo Alto

Auteurs 4

Nom	de Kort
Initiales	C
Institut	Netherlands Institute for Innovative Ocular Surgery
Ville	Rotterdam

Auteurs 5

Nom	Romano
Initiales	V
Institut	Eye Unit, University of Brescia
Ville	Brescia

Auteurs 6

Nom	Oellerich
Initiales	S
Institut	Department of Ophthalmology, UZ Brussel / Vrije Universiteit Brussel (VUB)
Ville	Brussels